Trial Profile

Study to Investigate the Effect of AB-101 in Breast Cancer Survivors

Status: Completed

Phase of Trial: Phase 0

Latest Information Update: 16 Mar 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs AB 101-Safety-Shot (Primary)
Indications Female sexual dysfunction
Focus Therapeutic Use
Sponsors Applied Biology

Most Recent Events

03 Mar 2020 Status changed from recruiting to completed.
04 Oct 2018 Planned End Date changed from 12 Nov 2018 to 12 Nov 2019.
04 Oct 2018 Planned primary completion date changed from 12 Nov 2018 to 12 Nov 2019.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com